Hematological Cancers Market Scope and Size by 2031
Hematological cancer is a class of cancer that affects the lymph nodes, blood, and bone marrow. It includes numerous forms such as lymphoma, leukemia, and myeloma. Leukemia is a malignancy in which abnormal white blood cells are formed in the bone marrow. Lymphoma is a blood cancer which develops in the lymphatic system. Myeloma is cancer associated with the plasma of the white blood cells. Hematological cancer is caused due to prolonged exposure to toxic substances such as chemical agents and ionizing radiation, genetic predisposition, viral infections, complex patient profiles, improper assessment, and risks associated with other diseases with decreased immunity.
MARKET DYNAMICS
The hematological cancers market is driving due to the increasing incidence of hematological cancers. However, low prevalence rate of myeloma is expected to restrain the growth of the global hematological cancers market during the forecast period. Moreover, rapidly increasing hematological cancer prevalence among the population pool, large investment by key market players, and a number of premium drugs commercially available are the factors driving the global hematological cancers market.
MARKET SCOPE
The "Hematological Cancers Market Analysis to 2031" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of hematological cancers market with detailed market segmentation by type and application. The hematological cancers market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in hematological cancers market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The hematological cancers market is segmented on the basis type and application. Based on type, the market is segmented as pharmacological therapies, stem cell transplantation, surgery and radiation therapy, anemia treatment, thrombosis treatment, neutopenia treatment and symptomatic treatment. On the basis of application, the market is categorized as epidemiology, pathophysiology of leukemic stem cells, kidney diseases, genetic diseases and other diseases.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the hematological cancers market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The hematological cancers market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting hematological cancers market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the hematological cancers market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the hematological cancers market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The hematological cancers market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting hematological cancers market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the hematological cancers market in these regions.
MARKET PLAYERS
The report covers key developments in the hematological cancers market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from hematological cancers market are anticipated to have lucrative growth opportunities in the future with the rising demand for hematological cancers in the global market. Below mentioned is the list of few companies engaged in the hematological cancers market.
The report also includes the profiles of key players in hematological cancers market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- AbbVie, Inc.
- Astellas Pharma US
- Bio-Rad Laboratories
- Bristol-Myers Squibb Company
- C. R. Bard
- Celgene Corporation
- GlaxoSmithKline plc
- Novartis International AG
- Otsuka Pharmaceutical Co., Ltd.
- Teva Pharmaceutical Industries Ltd.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Hematological Cancers Market - By Type
1.3.2 Hematological Cancers Market - By Application
1.3.3 Hematological Cancers Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HEMATOLOGICAL CANCERS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HEMATOLOGICAL CANCERS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HEMATOLOGICAL CANCERS MARKET - GLOBAL MARKET ANALYSIS
6.1. HEMATOLOGICAL CANCERS - GLOBAL MARKET OVERVIEW
6.2. HEMATOLOGICAL CANCERS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. HEMATOLOGICAL CANCERS MARKET - REVENUE AND FORECASTS TO 2028 – TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. PHARMACOLOGICAL THERAPIES
7.3.1. Overview
7.3.2. Pharmacological Therapies Market Forecast and Analysis
7.4. STEM CELL TRANSPLANTATION
7.4.1. Overview
7.4.2. Stem Cell Transplantation Market Forecast and Analysis
7.5. SURGERY AND RADIATION THERAPY
7.5.1. Overview
7.5.2. Surgery and Radiation Therapy Market Forecast and Analysis
7.6. ANEMIA TREATMENT
7.6.1. Overview
7.6.2. Anemia Treatment Market Forecast and Analysis
7.7. THROMBOSIS TREATMENT
7.7.1. Overview
7.7.2. Thrombosis Treatment Market Forecast and Analysis
7.8. NEUTOPENIA TREATMENT
7.8.1. Overview
7.8.2. Neutopenia Treatment Market Forecast and Analysis
7.9. SYMPTOMATIC TREATMENT
7.9.1. Overview
7.9.2. Symptomatic treatment Market Forecast and Analysis
8. HEMATOLOGICAL CANCERS MARKET - REVENUE AND FORECASTS TO 2028 – APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. EPIDEMIOLOGY
8.3.1. Overview
8.3.2. Epidemiology Market Forecast and Analysis
8.4. PATHOPHYSIOLOGY OF LEUKEMIC STEM CELLS
8.4.1. Overview
8.4.2. Pathophysiology of Leukemic Stem Cells Market Forecast and Analysis
8.5. KIDNEY DISEASES
8.5.1. Overview
8.5.2. Kidney Diseases Market Forecast and Analysis
8.6. GENETIC DISEASES
8.6.1. Overview
8.6.2. Genetic Diseases Market Forecast and Analysis
8.7. OTHER DISEASES
8.7.1. Overview
8.7.2. Other Diseases Market Forecast and Analysis
9. HEMATOLOGICAL CANCERS MARKET REVENUE AND FORECASTS TO 2028 – GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Hematological Cancers Market Overview
9.1.2 North America Hematological Cancers Market Forecasts and Analysis
9.1.3 North America Hematological Cancers Market Forecasts and Analysis - By Type
9.1.4 North America Hematological Cancers Market Forecasts and Analysis - By Application
9.1.5 North America Hematological Cancers Market Forecasts and Analysis - By Countries
9.1.5.1 United States Hematological Cancers Market
9.1.5.1.1 United States Hematological Cancers Market by Type
9.1.5.1.2 United States Hematological Cancers Market by Application
9.1.5.2 Canada Hematological Cancers Market
9.1.5.2.1 Canada Hematological Cancers Market by Type
9.1.5.2.2 Canada Hematological Cancers Market by Application
9.1.5.3 Mexico Hematological Cancers Market
9.1.5.3.1 Mexico Hematological Cancers Market by Type
9.1.5.3.2 Mexico Hematological Cancers Market by Application
9.2. EUROPE
9.2.1 Europe Hematological Cancers Market Overview
9.2.2 Europe Hematological Cancers Market Forecasts and Analysis
9.2.3 Europe Hematological Cancers Market Forecasts and Analysis - By Type
9.2.4 Europe Hematological Cancers Market Forecasts and Analysis - By Application
9.2.5 Europe Hematological Cancers Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Hematological Cancers Market
9.2.5.1.1 Germany Hematological Cancers Market by Type
9.2.5.1.2 Germany Hematological Cancers Market by Application
9.2.5.2 France Hematological Cancers Market
9.2.5.2.1 France Hematological Cancers Market by Type
9.2.5.2.2 France Hematological Cancers Market by Application
9.2.5.3 Italy Hematological Cancers Market
9.2.5.3.1 Italy Hematological Cancers Market by Type
9.2.5.3.2 Italy Hematological Cancers Market by Application
9.2.5.4 Spain Hematological Cancers Market
9.2.5.4.1 Spain Hematological Cancers Market by Type
9.2.5.4.2 Spain Hematological Cancers Market by Application
9.2.5.5 United Kingdom Hematological Cancers Market
9.2.5.5.1 United Kingdom Hematological Cancers Market by Type
9.2.5.5.2 United Kingdom Hematological Cancers Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Hematological Cancers Market Overview
9.3.2 Asia-Pacific Hematological Cancers Market Forecasts and Analysis
9.3.3 Asia-Pacific Hematological Cancers Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Hematological Cancers Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Hematological Cancers Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Hematological Cancers Market
9.3.5.1.1 Australia Hematological Cancers Market by Type
9.3.5.1.2 Australia Hematological Cancers Market by Application
9.3.5.2 China Hematological Cancers Market
9.3.5.2.1 China Hematological Cancers Market by Type
9.3.5.2.2 China Hematological Cancers Market by Application
9.3.5.3 India Hematological Cancers Market
9.3.5.3.1 India Hematological Cancers Market by Type
9.3.5.3.2 India Hematological Cancers Market by Application
9.3.5.4 Japan Hematological Cancers Market
9.3.5.4.1 Japan Hematological Cancers Market by Type
9.3.5.4.2 Japan Hematological Cancers Market by Application
9.3.5.5 South Korea Hematological Cancers Market
9.3.5.5.1 South Korea Hematological Cancers Market by Type
9.3.5.5.2 South Korea Hematological Cancers Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Hematological Cancers Market Overview
9.4.2 Middle East and Africa Hematological Cancers Market Forecasts and Analysis
9.4.3 Middle East and Africa Hematological Cancers Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Hematological Cancers Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Hematological Cancers Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Hematological Cancers Market
9.4.5.1.1 South Africa Hematological Cancers Market by Type
9.4.5.1.2 South Africa Hematological Cancers Market by Application
9.4.5.2 Saudi Arabia Hematological Cancers Market
9.4.5.2.1 Saudi Arabia Hematological Cancers Market by Type
9.4.5.2.2 Saudi Arabia Hematological Cancers Market by Application
9.4.5.3 U.A.E Hematological Cancers Market
9.4.5.3.1 U.A.E Hematological Cancers Market by Type
9.4.5.3.2 U.A.E Hematological Cancers Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Hematological Cancers Market Overview
9.5.2 South and Central America Hematological Cancers Market Forecasts and Analysis
9.5.3 South and Central America Hematological Cancers Market Forecasts and Analysis - By Type
9.5.4 South and Central America Hematological Cancers Market Forecasts and Analysis - By Application
9.5.5 South and Central America Hematological Cancers Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Hematological Cancers Market
9.5.5.1.1 Brazil Hematological Cancers Market by Type
9.5.5.1.2 Brazil Hematological Cancers Market by Application
9.5.5.2 Argentina Hematological Cancers Market
9.5.5.2.1 Argentina Hematological Cancers Market by Type
9.5.5.2.2 Argentina Hematological Cancers Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL HEMATOLOGICAL CANCERS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. HEMATOLOGICAL CANCERS MARKET, KEY COMPANY PROFILES
12.1. ABBVIE, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ASTELLAS PHARMA US
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BIO-RAD LABORATORIES
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BRISTOL-MYERS SQUIBB COMPANY
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. C. R. BARD
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. CELGENE CORPORATION
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GLAXOSMITHKLINE PLC
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. NOVARTIS INTERNATIONAL AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. OTSUKA PHARMACEUTICAL CO., LTD.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. TEVA PHARMACEUTICAL INDUSTRIES LTD.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. AbbVie, Inc.
2. Astellas Pharma US
3. Bio-Rad Laboratories
4. Bristol-Myers Squibb Company
5. C. R. Bard
6. Celgene Corporation
7. GlaxoSmithKline plc
8. Novartis International AG
9. Otsuka Pharmaceutical Co., Ltd.
10. Teva Pharmaceutical Industries Ltd.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For